Should molecular subtype be recommended as one of the selection criteria for accelerated partial breast irradiation? Preliminary results from an Asian cohort

PURPOSE: The purpose of this study was to report clinical outcomes in patients treated with accelerated partial breast irradiation (APBI), stratified as per molecular subtype and American Society for Therapeutic Radiology and Oncology/Groupe Européen de Curiethérapie and European Society for Radioth...

Descripción completa

Detalles Bibliográficos
Autores principales: Wadasadawala, Tabassum, Mondal, Monidipa, Paul, Siji Nojin, Parmar, Vani, Nair, Nita, Shet, Tanuja, Desai, Sangeeta, Gupta, Sudeep, Sarin, Rajiv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881594/
https://www.ncbi.nlm.nih.gov/pubmed/29619056
http://dx.doi.org/10.5114/jcb.2018.74137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881594/
https://www.ncbi.nlm.nih.gov/pubmed/29619056
http://dx.doi.org/10.5114/jcb.2018.74137

Ejemplares similares